Leukocyte ligands for endothelial selectins: Specialized glycoconjugates that mediate rolling and signaling under flow

Blood

Volumn 118, Issue 26, 2011, Pages 6743-6751

  Zarbock, Alexander ^a   Ley, Klaus ^b   McEver, Rodger P ^c   Hidalgo, Andrés ^d  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; E SELECTIN LIGAND 1; GLYCOCONJUGATE; GLYCOLIPID; HERMES ANTIGEN; L SELECTIN; LEUKOSIALIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; P SELECTIN GLYCOPROTEIN LIGAND 1; SELECTIN; UNCLASSIFIED DRUG;

ENDOTHELIUM; HUMAN; LEUKOCYTE; LEUKOCYTE ADHERENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84255186460     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-343566     Document Type: Review

References (115)

1. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev. 1999;79(1):181-213. (Pubitemid 29056952)
2. McEver RP, Zhu C. Rolling cell adhesion. Annu Rev Cell Dev Biol. 2010;26:363-396.
3. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678-689. (Pubitemid 47327397)
4. Homeister JW, Thall AD, Petryniak B, et al. The alpha(1,3) fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity. 2001;15(1):115-126. (Pubitemid 32728325)
5. Wilkins PP, McEver RP, Cummings RD. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. J Biol Chem. 1996;271(31):18732-18742. (Pubitemid 26322741)
6. Kobzdej MM, Leppanen A, Ramachandran V, Cummings RD, McEver RP. Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. Blood. 2002;100(13):4485-4494. (Pubitemid 35429689)
7. Norman KE, Moore KL, McEver RP, Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood. 1995;86(12):4417-4421.
8. Xia L, Sperandio M, Yago T, et al. P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest. 2002;109(7):939-950. (Pubitemid 34275115)
9. Hirata T, Merrill-Skoloff G, Aab M, Yang J, Furie BC, Furie B. P-selectin glycoprotein ligand 1 (PSGL-1) is a physiological ligand for E-selectin in mediating T helper 1 lymphocyte migration. J Exp Med. 2000;192(11):1669-1676.
10. Sperandio M, Smith ML, Forlow SB, et al. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med. 2003;197(10):1355-1363. (Pubitemid 36617782)
11. Zarbock A, Muller H, Kuwano Y, Ley K. PSGL-1-dependent myeloid leukocyte activation. J Leukoc Biol. 2009;86(5):1119-1124.
12. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005;106(5):1604-1611. (Pubitemid 41208572)
13. Moore KL, Patel KD, Bruehl RE, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol. 1995;128(4):661-671.
14. McEver RP. P-selectin glycoprotein ligand-1 (PSGL-1). In: Ley K, ed. Adhesion Molecules: Function and Inhibition. Basel, Switzerland: Birkhauser Verlag; 2007:3-26.
15. McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997;100(11 suppl):S97-S103. (Pubitemid 28009555)
16. Afshar-Kharghan V, Diz-Kucukkaya R, Ludwig EH, Marian AJ, Lopez JA. Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region. Blood. 2001;97(10):3306-3307.
17. Yang J, Galipeau J, Kozak CA, Furie BC, Furie B. Mouse P-selectin glycoprotein ligand-1: molecular cloning, chromosomal localization, and expression of a functional P-selectin receptor. Blood. 1996;87(10):4176-4186. (Pubitemid 26152262)
18. Tenno M, Ohtsubo K, Hagen FK, et al. Initiation of protein O glycosylation by the polypeptide GalN-AcT-1 in vascular biology and humoral immunity. Mol Cell Biol. 2007;27(24):8783-8796.
19. Schachter H, Brockhausen I. The biosynthesis of branched O-glycans. Symp Soc Exp Biol. 1989;43:1-26.
20. Ellies LG, Tsuboi S, Petryniak B, Lowe JB, Fukuda M, Marth JD. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity. 1998;9(6):881-890. (Pubitemid 29024467)
21. Smith MJ, Smith BR, Lawrence MB, Snapp KR. Functional analysis of the combined role of the O-linked branching enzyme core 2 beta1-6-N- glucosaminyltransferase and dimerization of P-selectin glycoprotein ligand-1 in rolling on P-selectin. J Biol Chem. 2004;279(21):21984-21991. (Pubitemid 38679389)
22. Snapp KR, Heitzig CE, Ellies LG, Marth JD, Kansas GS. Differential requirements for the O-linked branching enzyme core 2 beta1-6-N- glucosaminyltransferase in biosynthesis of ligands for E-selectin and P-selectin. Blood. 2001;97(12):3806-3811.
23. Sperandio M, Thatte A, Foy D, Ellies LG, Marth JD, Ley K. Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase- deficient mice. Blood. 2001;97(12):3812-3819.
24. Xia L, Ramachandran V, McDaniel JM, Nguyen KN, Cummings RD, McEver RP. N-terminal residues in murine P-selectin glycoprotein ligand-1 required for binding to murine P-selectin. Blood. 2003;101(2):552-559. (Pubitemid 36077577)
25. Westmuckett AD, Thacker KM, Moore KL. Tyrosine sulfation of native mouse Psgl-1 is required for optimal leukocyte rolling on p-selectin in vivo. PLoS One. 2011;6(5):e20406.
26. Yago T, Fu J, McDaniel JM, Miner JJ, McEver RP, Xia L. Core 1-derived O-glycans are essential E-selectin ligands on neutrophils. Proc Natl Acad Sci U S A. 2010;107(20):9204-9209.
27. Hirata T, Furukawa Y, Yang BG, et al. Human P-selectin glycoprotein ligand-1 (PSGL-1) interacts with the skin-associated chemokine CCL27 via sulfated tyrosines at the PSGL-1 amino terminus. J Biol Chem. 2004;279(50):51775-51782. (Pubitemid 39656544)
28. Veerman KM, Williams MJ, Uchimura K, et al. Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs. Nat Immunol. 2007;8(5):532-539. (Pubitemid 46605921)
29. Epperson TK, Patel KD, McEver RP, Cummings RD. Noncovalent association of P-selectin glycoprotein ligand-1 and minimal determinants for binding to P-selectin. J Biol Chem. 2000;275(11):7839-7853. (Pubitemid 30159691)
30. Miner JJ, Shao B, Wang Y, et al. Cytoplasmic domain of P-selectin glycoprotein ligand-1 facilitates dimerization and export from the endoplasmic reticulum. J Biol Chem. 2011;286(11):9577-9586.
31. Alonso-Lebrero JL, Serrador JM, Dominguez-Jimenez C, et al. Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells. Blood. 2000;95(7):2413-2419. (Pubitemid 30167744)
32. Urzainqui A, Serrador JM, Viedma F, et al. ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. Immunity. 2002;17(4):401-412. (Pubitemid 35223530)
33. Wang HB, Wang JT, Zhang L, et al. P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol. 2007;8(8):882-892. (Pubitemid 47099040)
34. Schaff UY, Shih HH, Lorenz M, et al. SLIC-1/sorting nexin 20: a novel sorting nexin that directs subcellular distribution of PSGL-1. Eur J Immunol. 2008;38(2):550-564.
35. Borges E, Eytner R, Moll T, et al. The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. Blood. 1997;90(5):1934-1942. (Pubitemid 27377304)
36. Borges E, Tietz W, Steegmaier M, et al. P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med. 1997;185(3):573-578. (Pubitemid 27078375)
37. Yang J, Hirata T, Croce K, et al. Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J Exp Med. 1999;190(12):1769-1782. (Pubitemid 30013843)
38. Hidalgo A, Peired AJ, Wild MK, Vestweber D, Frenette PS. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity. 2007;26(4):477-489. (Pubitemid 46603003)
39. Katayama Y, Hidalgo A, Chang J, Peired A, Frenette PS. CD44 is a physiological E-selectin ligand on neutrophils. J Exp Med. 2005;201(8):1183- 1189. (Pubitemid 40637228)
40. Yago T, Shao B, Miner JJ, et al. E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood. 2010;116(3):485-494.
41. Merzaban JS, Burdick MM, Gadhoum SZ, et al. Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells. Blood. 2011;118(7):1774-1783.
42. Sackstein R. The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. J Invest Dermatol. 2004;122(5):1061-1069. (Pubitemid 38651076)
43. Nacher M, Blazquez AB, Shao B, et al. Physiological contribution of CD44 as a ligand for E-selectin during inflammatory T-cell recruitment. Am J Pathol. 2011;178(5):2437-2446.
44. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A. 1992;89(24):12160- 12164. (Pubitemid 23004805)
45. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271-335. (Pubitemid 23289255)
46. Ruiz P, Schwarzler C, Gunthert U. CD44 isoforms during differentiation and development. Bioessays. 1995;17(1):17-24.
47. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol. 1994;6(5):726-733. (Pubitemid 24295307)
48. Sleeman JP, Kondo K, Moll J, Ponta H, Herrlich P. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J Biol Chem. 1997;272(50):31837-31844. (Pubitemid 28013335)
49. Katoh S, Miyagi T, Taniguchi H, et al. Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol. 1999;162(9):5058-5061. (Pubitemid 29307104)
50. Maiti A, Maki G, Johnson P. TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation. Science. 1998;282(5390):941-943. (Pubitemid 28507526)
51. Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol. 1998;140(2):431-446. (Pubitemid 28078406)
52. Levesque MC, Haynes BF. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. J Immunol. 1997;159(12):6184-6194. (Pubitemid 127471559)
53. Perschl A, Lesley J, English N, Hyman R, Trowbridge IS. Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J Cell Sci. 1995;108(3):1033-1041.
54. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003;4(1):33-45. (Pubitemid 36077255)
55. Schmits R, Filmus J, Gerwin N, et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood. 1997;90(6):2217-2233. (Pubitemid 27392706)
56. Bonder CS, Clark SR, Norman MU, Johnson P, Kubes P. Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. Blood. 2006;107(12):4798-4806. (Pubitemid 43882631)
57. DeGrendele HC, Estess P, Picker LF, Siegelman MH. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte- endothelial cell primary adhesion pathway. J Exp Med. 1996;183(3):1119-1130. (Pubitemid 26113975)
58. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 1997;278(5338):672-675. (Pubitemid 27464963)
59. DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol. 1997;159(6):2549-2553. (Pubitemid 127681269)
60. Hutas G, Bajnok E, Gal I, Finnegan A, Glant TT, Mikecz K. CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood. 2008;112(13):4999-5006.
61. Khan AI, Kerfoot SM, Heit B, et al. Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol. 2004;173(12):7594-7601. (Pubitemid 39628201)
62. McDonald B, McAvoy EF, Lam F, et al. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med. 2008;205(4):915-927. (Pubitemid 351549887)
63. Szanto S, Gal I, Gonda A, Glant TT, Mikecz K. Expression of L-selectin, but not CD44, is required for early neutrophil extravasation in antigen-induced arthritis. J Immunol. 2004;172(11):6723-6734. (Pubitemid 38669109)
64. Siegelman MH, Stanescu D, Estess P. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion. J Clin Invest. 2000;105(5):683-691. (Pubitemid 30146515)
65. Nandi A, Estess P, Siegelman M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest: CD44 association with VLA-4 in T cell extravasation. Immunity. 2004;20(4):455-465. (Pubitemid 38482123)
66. Gonatas JO, Mourelatos A, Stieber A, Lane WS, Brosius J, Gonatas NK. MG-160, a membrane sialoglycoprotein of the medial cisternae of the rat Golgi apparatus, binds basic fibroblast growth factor and exhibits a high level of sequence identity to a chicken fibroblast growth factor receptor. J Cell Sci. 1995;108(2):457-467.
67. Steegmaier M, Levinovitz A, Isenmann S, et al. The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature. 1995;373(6515):615-620.
68. Gonatas JO, Chen YJ, Stieber A, Mourelatos Z, Gonatas NK. Truncations of the C-terminal cytoplasmic domain of MG160, a medial Golgi sialoglycoprotein, result in its partial transport to the plasma membrane and filopodia. J Cell Sci. 1998;111(2):249-260. (Pubitemid 28064149)
69. Steegmaier M, Borges E, Berger J, Schwarz H, Vestweber D. The E-selectin-ligand ESL-1 is located in the Golgi as well as on microvilli on the cell surface. J Cell Sci. 1997;110(6):687-694. (Pubitemid 27156318)
70. Miyaoka Y, Tanaka M, Imamura T, Takada S, Miyajima A. A novel regulatory mechanism for Fgf18 signaling involving cysteine-rich FGF receptor (Cfr) and delta-like protein (Dlk). Development. 2010;137(1):159-167.
71. Dimitroff CJ, Descheny L, Trujillo N, et al. Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res. 2005;65(13):5750-5760. (Pubitemid 40911178)
72. Lenter M, Levinovitz A, Isenmann S, Vestweber D. Monospecific and common glycoprotein ligands for E- and P-selectin on myeloid cells. J Cell Biol. 1994;125(2):471-481. (Pubitemid 24135959)
73. Levinovitz A, Muhlhoff J, Isenmann S, Vestweber D. Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells. J Cell Biol. 1993;121(2):449-459. (Pubitemid 23110887)
74. Zhou Z, Zuber ME, Burrus LW, Olwin BB. Identification and characterization of a fibroblast growth factor (FGF) binding domain in the cysteine-rich FGF receptor. J Biol Chem. 1997;272(8):5167-5174. (Pubitemid 27090074)
75. Yang T, Mendoza-Londono R, Lu H, et al. E-selectin ligand-1 regulates growth plate homeostasis in mice by inhibiting the intracellular processing and secretion of mature TGF-beta. J Clin Invest. 2010;120(7):2474-2485.
76. Huang MC, Zollner O, Moll T, et al. P-selectin glycoprotein ligand-1 and E-selectin ligand-1 are differentially modified by fucosyltransferases Fuc-TIV and Fuc-TVII in mouse neutrophils. J Biol Chem. 2000;275(40):31353-31360.
77. Kuwano Y, Spelten O, Zhang H, Ley K, Zarbock A. Rolling on E- or P-selectin induces the extended but not high-affinity conformation of LFA-1 in neutrophils. Blood. 2010;116(4):617-624.
78. Miner JJ, Xia L, Yago T, et al. Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow. Blood. 2008;112(5):2035-2045.
79. Zarbock A, Lowell CA, Ley K. Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity. 2007;26(6):773-783. (Pubitemid 46907666)
80. Patel KD, Moore KL, Nollert MU, McEver RP. Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions. J Clin Invest. 1995;96(4):1887-1896.
81. Dunne JL, Ballantyne CM, Beaudet AL, Ley K. Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1. Blood. 2002;99(1):336-341.
82. Zarbock A, Abram CL, Hundt M, Altman A, Lowell CA, Ley K. PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J Exp Med. 2008;205(10):2339- 2347.
83. Mueller H, Stadtmann A, Van Aken H, et al. Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways. Blood. 2010;115(15):3118-3127.
84. Stadtmann A, Brinkhaus L, Mueller H, et al. Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling. Eur J Immunol. 2011;41(7):2074-2085.
85. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med. 2009;15(4):384-391.
86. von Andrian UH, Hasslen SR, Nelson RD, Erlandsen SL, Butcher EC. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell. 1995;82(6):989-999.
87. Green CE, Pearson DN, Camphausen RT, Staunton DE, Simon SI. Shear-dependent capping of L-selectin and P-selectin glycoprotein ligand 1 by E-selectin signals activation of high-avidity beta2-integrin on neutrophils. J Immunol. 2004;172(12):7780-7790. (Pubitemid 38747646)
88. Eto T, Winkler I, Purton LE, Levesque JP. Contrasting effects of P-selectin and E-selectin on the differentiation of murine hematopoietic progenitor cells. Exp Hematol. 2005;33(2):232-242. (Pubitemid 40164906)
89. Urzainqui A, Martinez G, del Hoyo A, et al. Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J Immunol. 2007;179(11):7457-7465.
90. Nunez-Andrade N, Lamana A, Sancho D, et al. P-selectin glycoprotein ligand-1 modulates immune inflammatory responses in the enteric lamina propria. J Pathol. 2011;224(2):212-221.
91. Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci U S A. 2002;99(5):3047-3051. (Pubitemid 34240583)
92. Alcaide P, King SL, Dimitroff CJ, Lim YC, Fuhlbrigge RC, Luscinskas FW. The 130-kDa glycoform of CD43 functions as an E-selectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo. J Invest Dermatol. 2007;127(8):1964-1972. (Pubitemid 47075363)
93. Matsumoto M, Atarashi K, Umemoto E, et al. CD43 functions as a ligand for E-selectin on activated T cells. J Immunol. 2005;175(12):8042-8050. (Pubitemid 41798366)
94. Matsumoto M, Shigeta A, Furukawa Y, Tanaka T, Miyasaka M, Hirata T. CD43 collaborates with P-selectin glycoprotein ligand-1 to mediate E-selectin-dependent T cell migration into inflamed skin. J Immunol. 2007;178(4):2499-2506. (Pubitemid 46233451)
95. Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL, Butcher EC. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell. 1991;66(5):921-933. (Pubitemid 121001726)
96. Zollner O, Lenter MC, Blanks JE, et al. L-selectin from human, but not from mouse neutrophils binds directly to E-selectin. J Cell Biol. 1997;136(3):707-716. (Pubitemid 27083770)
97. Kuijpers TW, Hoogerwerf M, van der Laan LJ, et al. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J Cell Biol. 1992;118(2):457-466.
98. Crutchfield KL, Shinde VR, Patil CJ, et al. CD11b/CD18-coated microspheres attach to E-selectin under flow. J Leukoc Biol. 2000;67(2):196-205.
99. Barthel SR, Wiese GK, Cho J, et al. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci U S A. 2009;106(46):19491-19496.
100. Stockton BM, Cheng G, Manjunath N, Ardman B, von Andrian UH. Negative regulation of T cell homing by CD43. Immunity. 1998;8(3):373-381. (Pubitemid 28188897)
101. Woodman RC, Johnston B, Hickey MJ, et al. The functional paradox of CD43 in leukocyte recruitment: a study using CD43-deficient mice. J Exp Med. 1998;188(11):2181-2186. (Pubitemid 28562534)
102. Fuhlbrigge RC, King SL, Sackstein R, Kupper TS. CD43 is a ligand for E-selectin on CLA+ human T cells. Blood. 2006;107(4):1421-1426. (Pubitemid 43242377)
103. Carlow DA, Ziltener HJ. CD43 deficiency has no impact in competitive in vivo assays of neutrophil or activated T cell recruitment efficiency. J Immunol. 2006;177(9):6450-6459. (Pubitemid 44628864)
104. Yonemura S, Nagafuchi A, Sato N, Tsukita S. Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons. J Cell Biol. 1993;120(2):437-449. (Pubitemid 23040082)
105. Varki A. Selectin ligands. Proc Natl Acad Sci U S A. 1994;91(16):7390- 7397. (Pubitemid 24238190)
106. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 2003;3(11):867-878. (Pubitemid 37411716)
107. Tedder TF, Steeber DA, Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med. 1995;181(6):2259-2264.
108. Stein JV, Cheng G, Stockton BM, Fors BP, Butcher EC, von Andrian UH. L-selectin-mediated leukocyte adhesion in vivo: microvillous distribution determines tethering efficiency, but not rolling velocity. J Exp Med. 1999;189(1):37-50.
109. Alon R, Fuhlbrigge RC, Finger EB, Springer TA. Interactions through L-selectin between leukocytes and adherent leukocytes nucleate rolling adhesions on selectins and VCAM-1 in shear flow. J Cell Biol. 1996;135(3):849-865. (Pubitemid 26372938)
110. Guyer DA, Moore KL, Lynam EB, et al. P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood. 1996;88(7):2415-2421. (Pubitemid 26327489)
111. Walcheck B, Moore KL, McEver RP, Kishimoto TK. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1: a mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest. 1996;98(5):1081-1087. (Pubitemid 26299918)
112. Tiemeyer M, Swiedler SJ, Ishihara M, et al. Carbohydrate ligands for endothelial-leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A. 1991;88(4):1138-1142. (Pubitemid 21916180)
113. Alon R, Feizi T, Yuen CT, Fuhlbrigge RC, Springer TA. Glycolipid ligands for selectins support leukocyte tethering and rolling under physiologic flow conditions. J Immunol. 1995;154(10):5356-5366.
114. Nimrichter L, Burdick MM, Aoki K, et al. E-selectin receptors on human leukocytes. Blood. 2008;112(9):3744-3752.
115. Yago T, Leppanen A, Qiu H, et al. Distinct molecular and cellular contributions to stabilizing selectin-mediated rolling under flow. J Cell Biol. 2002;158(4):787-799. (Pubitemid 34920116)